Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235) 1

Author： Kucuk O.   Fisher E.   Moinpour C.M.   Coleman D.   Hussain M.H.A.   Sartor A.O.   Chatta G.S.   Lowe B.A.   Eisenberger M.A.   Crawford E.D.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.58, Iss.1, 2001-07, pp. : 53-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer - a controlled study

By Smith D.C.   Redman B.G.   Flaherty L.E.   LI L.   Strawderman M.   Pienta K.J.  

Urology, Vol. 52, Iss. 2, 1998-08 ,pp. : 257-260

Elsevier

Access to resources Recommend Favorite

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

By Schellhammer P.   Sharifi R.   Block N.   Soloway M.   Venner P.   Patterson A.L.   Sarosdy M.   Vogelzang N.   Jones J.   Kolvenbag G.  

Urology, Vol. 45, Iss. 5, 1995-05 ,pp. : 745-752

Elsevier

Access to resources Recommend Favorite

The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group

By Samelis G.F.   Skarlos D.   Bafaloukos D.   Kosmidis P.   Anagnostopoulos A.   Aravantinos G.   Dimopoulos M.A.  

Urology, Vol. 61, Iss. 6, 2003-06 ,pp. : 1211-1215

Elsevier

Access to resources Recommend Favorite

Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

By Wirth M.   Tyrrell C.   Wallace M.   Delaere K.P.   Sanchez-Chapado M.   Ramon J.   Hetherington J.   Pina F.   Heynes C.F.   Borchers T.M.   Morris T.   Stone A.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 146-150

Elsevier

Access to resources Recommend Favorite

Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder - a Southwest Oncology Group study

By Gohji K.   Nomi M.   Okamoto M.   Takenaka A.   Hara I.   Okada H.   Arakawa S.   Fujii A.   Kamidono S.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 308-313

Elsevier

Access to resources Recommend Favorite